書籍詳細

1. 大腸の構造と機能

P.16 掲載の参考文献

• 1) Goligher, J. C. and Hughes, E. S. R.:Sensibility of the rectum and colon:Its role in the mechanism of anal continence. Lancet, 1:543 547, 1951.

• 2) 福原武:消化管運動研究の回顧. 日本平滑筋学会雑誌, 13:224-226, 1977.

• 3) Christensen, J.:Myoelectric control of the colon. Gastroenterology, 68:601-609, 1975.
  pubmed

• 4) Sarna, S. K.:Human colonic electrical control activity. Gastroenterology, 78:1526-1536, 1980.
  pubmed

• 5) Shepherd, J. J.:Anorectal function in 'Scientific foundation of gastroenterology" edited by Sircus, W. and Smith, A. N., William Heinemann Medical Books, London, p. 499-511, 1980.

• 6) Duthie, H. L.:Large intestinal motility in "Scientific basis of gastroenterology:edited by Duthie, H. L. and Wormsley, K. G., Churchill Livingstone, Edinburgh, 470-484, 1979.

• 7) Weems, W. A. and Szurszewski, J. H.:Modulation of colonic motility by peripheral neural inputs to neurons of the inferior mesenteric ganglion. Gastroenterology, 73:273 278, 1977.

• 8) Semba, T. and Mizonishi, T.:Atropine-resistent excitation of motility of the dog stomach and colon induced by stimulation of the extrinsic nerves and their centers. Jap. J. Physiol., 28:239-248, 1978.

• 9) 大賀晧:消化管運動抑制の神経機構, 板東丈夫, 高木敬次郎, 江橋節郎編:平滑筋の生理および薬理. 南江堂, 東京, P. 115-137, 1974.

• 10) Yokoyama, S. and Ozaki, T:Functions of Auerbach's plexus. 日本平滑筋学会雑誌, 14:173-187, 1978.

• 11) Wood, J. D.:Neurophysiology of Auerbach's Plexus and control of intestinal motility. Physiol. Rev., 55:307-324, 1975.
  pubmed

• 12) Burnstock, G.:Purinergic nerves. Pharmacol. Rev., 24:509-581, 1972.
  pubmed

• 13) Furness, J. B. and Costa, M.:Commentary types of nerves in the enteric nervous system. Neuroscience, 5:1-20, 1980.

• 14) Benett, A.:Pharmacology of colonic muscle, Gut, 16:307-311, 1975.

• 15) Pearse, A. G. E.:The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J. Histochem., 17:303-313, 1969.

• 16) Polak, J. M. and Bloom, S. R.:The diffuse neuroendocrine system in gastoenterology. Biochem. Soc. Trans., *:19-22, 1980.

• 17) 藤田恒夫:パラニューロンとしての胃腸膵内分泌細胞. 医学のあゆみ, 104: 45-49, 1978.

• 18) 柳谷岩雄, 矢ヶ崎修:腸管蠕動とアセチルコリン. 板東丈夫, 高木敬次郎, 江橋節郎編:平滑筋の生理および薬理. 南江堂, 東京, p. 264-281, 1974.

• 19) Anggard, E.:Studies on the analysis and metabolism of the prostaglandins. Ann. N. Y. Acd, Sci. 180:200-217, 1971.

• 20) 伊藤漸, 相沢勇, 竹内真人:プロスタグランディンと消化管 (腸) . 代謝, 12:1583-1595, 1975.

• 21) Misiewicz, J. J.:Large intestine:Motility in 'Scientific foundation of gastroenterology' edited by Sircus, W. and Smith, A. N., Wiliam Heinemann Medical Books, p. 483-491, 1980.

• 22) Taylor, I., Duthie, H. L., Smallwood, R., Broom, B. H. and Linkens, D.:The effect of stimulation on myoelectrical activity of rectosigmoid in man. Gut, 15:599-607, 1974.

• 23) Harvey, R. F. and Read, A. E.:Effect of choledystokinin on colonic motility and symptoms in patients with irritable bowel syndrome. Lancet, 1:1-3, 1973.
  pubmed

• 24) Snape, W. J, JR., Matarazzo, S. A. and Cohen, S.:Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity. Gastroenterology, 75:373-378, 1978.
  pubmed

• 25) Rennie, J. A., Christofides, N. D., Bloom, S. R. and Johnson, A. G.:Stimulation of human colonic activity by motilin. Gut, 20:A912-912, 1979.

• 26) Bloom, S. R. and Polak, J. M.:Physiology of gastrointestinal hormones. Biochem. Soc. Trans., 8:15-17, 1980.
  pubmed

• 27) 伊藤漸, 竹内真人, 相沢勇:消化管運動調節におけるパラニューロンの役割. 104:755-762, 1978.

• 28) Wright, S. H., Snape, W. J., JR., Battle, W., Cohen, S. and London, R. L.:Effect of dietary components on gastrocolollic response. Amer. J. Physiol., 238:G228-232, 1980.
  pubmed

• 29) Edmonds, C. J.:Electrical potential difference of colonic mucosa. gut, 16:315-318, 1975.
  pubmed

• 30) Allan, R., Steinberg, D. M., Dixon, K. and Cooke, W. T.:Changes in the bidirectional sodium flux across the intestinal mucosa in Crohn's disease. Gut, 16:201-204, 1975.
  pubmed

P.34 掲載の参考文献

• 1) Hollman, K. H.:Ueber den Feinbau des Rectumepithels. Z. Zellforsch. mikrosk. Anat, 68:502, 1965.

• 2) 緒方卓郎, 村田文雄:走査電子顕微鏡による大腸粘膜の観察. 臨床外科, 25: グラフ, 1970.

• 3) Hampton, J. C.:An electron microscopic study of mouse colon. Dis, Colon Rectum 3:423, 1960.
  pubmed

• 4) Hayard, A. F. and Johnson, H. S.:The fine structure of the epithelium of the colon in the mouse. Scott. med. J. 6:416, 1961.

• 5) Lorenzsonn, V. and Trier, J. S.:The fine structure of human rectal mucosa. The epithelial lining of the crypt. Gastroenterology 55:88, 1968.
  pubmed

• 6) Nagle, G. J. and Kurtz, S. M.:Electron microscopy of the human rectal mucosa. A comparison of idiopathic ulcerative colitis with inflammation of known etiologies. Am. J. dig. Dis. NS 12:541, 1967.

• 7) Lane, N., et al.:On the site of sulfation in colonic goblet cells. J. Cell Biol. 21:339, 1964.
  pubmed

• 8) Neutra, M. and Leblond, C. P.:Synthesis of the carbohydrate of mucus in the Golgi complex as shown by electron microscope radioautography of goblet cells from rats injected with glucose-H3. J. cell Biol. 30:119, 1966.
  pubmed

• 9) Berlin, J. D.:The localisation of acid mucopolysaccharides within Golgi complex of intestinal goblet cells. J. Cell Biol. 32:760, 1967.
  pubmed

• 10) Schofield, G. C.:Colummar cells with secretory granules in the large intestine of the macaque (cynamolgus irus). J. Anat. 106:1, 1970.

• 11) Chang, W. W. L., and Leblond, C. P.:Renewal of the epithelium in the descending colon of the mouse. I. Presence of three epithelial cell populations:vacuolated-columnar, mucous and argentaffin. Am. J. Anat. 131:73, 1971.

• 12) Michitoshi Osaka, et al.:The endocrine cells in the human colon and rectum. An electron microscope study of biopsy materials. Arch. Histol. Jap. 33:247, 1971.

• 13) 片岡勝子:消化管の内分泌系細胞. 消化管, 機能と病態, 中外医学社:75, 1981.

• 14) Solcia, E., et al.:Lausanne 1977 classification of gastroenteropancreatic emdocrine cells. "Gut Hormones" ed. by Bloom, S. R., 1978, 40-48, Chirchill Livingstone, Edinburgh, London &New York.

• 15) 白鳥ほか:大腸の解剖と機能. 外科治療 40:143, 1979.

• 16) Cummings, J. H.:Absorption and secretion by the colon. Gut 16:323. 1975.
  pubmed

• 17) Kanaghinis, T., et al.:The composition of ileostomy fluid. Gut 4:322, 1963.
  pubmed

• 18) Carter, M. J. and Parsons, D. S.:Carbonic anhydrase activity of mucosa of small intestine and colon. Nature 219:176, 1968.
  pubmed

• 19) Levitan, R., et al.:Water and salt absorption in the human colon. J. Clin. Invest. 41:1754, 1962.

• 20) 鈴木, 腸管における電解質輸送に関する研究, 日消会誌 70:31-40, 昭48.

• 21) Richards, P.:Clinical investigation of the effects of adrenal corticosteroid excess on the colon. Rancet 1:437, 1969.
  pubmed

• 22) Shields, R., et al.:Action of aldosterone upon the intestinal trasport of potassium, sodium and water. Gut 7:686, 1966.

• 23) Elmslie, R. G., et al.:Blocking by spironolactone (SC 9420) of the action of aldosterone upon the intestinal transport of potassium, sodium and water. Gut 7:697, 1966.
  pubmed

• 24) Davies, N. T., et al.:The effect of angiotensin on rat intestine fluid tranfer. J. Endocr 48:39, 1970.

• 25) Gingell, J. C., et al.:Effects of a synthetic gastrin-like pentapeptide upon the intestinal transport of sodium, potassium and water. Gut 9:111, 1968.
  pubmed

• 26) Cummings, J. H., et al.:Studies on the site of Production of diarrhoea induced by prostaglandins. (Abst.) Clin. Sci. 46:15, 1974.

• 27) Milton-Thompson, G. J., et al.:Colonic and small intestinal response to intravenous prostaglandin F2α and E2 in man. Gut 16:42, 1975.

• 28) Duthie, H. L., et al.:Serum electrolytes and colonic transfer of water and electrolytes in chronic ulcerative colitis. Gastroenterology 47:525, 1964.
  pubmed

• 29) Head, L. H., et al.:absorption of water aud electrolytes in Crohn's disease of the Colon. Gastroenterology 56:571, 1969.

• 30) Archampong, E. Q., et al:The absorption and secretion of water and electrolytes across the healthy and the diseased human colonic mucosa measured in vitro. Gut 13:880, 1972.
  pubmed

• 31) Shields, R.:Absorption and secretion of electrolytes and water by the human colon, with particular reference to benign adenoma and papilloma. Brit. G. Surg. 53:893, 1966.

• 32) Turnberg, L. A.:Abnormalities in intestinal electrolyte transport in congenital chloridorrhoea. Gut 12:544, 1971.
  pubmed

• 33) Pearson, A. J. G., et al.:The pathophysiology of congenital chloridorrhoea. Quart. J. Med. 42:453, 1973.

• 34) Aoyagi, T., et al.:Gastrointestinal urease in man. I. Activity of mucosal urease. Gut 7:631, 1966.

• 35) Evans, W. B., et al.:Gastrointestinal urease in man. II. Urea hydrolysis and ammonia absorption in upper and lower gut lumen and the effect of neomycin. Gut 7:635, 1966.
  pubmed

• 36) Dawson, A. M.:Regulation of blood ammonia. Gut 191504, 1978.

• 37) Rubinstein, R., et al.:In vivo dialysis of feces as a method of stool analysis. Clin. Sci. 37:549, 1969.
  pubmed

• 38) McNeil, N. I., et al.:Short chain fatty acid absorption by thc human large intestine. Gut 19:819, 1978.

• 39) Cummings, J. H., et al.:The role of the colon in ilealresection diarrhoea. Lancet 1:344, 1973.

• 40) 福島ほか, 潰瘍性大腸炎症例における尿中蓚酸の変動. 日消会誌24:182, 昭52.

2. 大腸疾患の診断法

P.58 掲載の参考文献

• 1) 西沢護, 狩谷淳:大腸X線診断, 文光堂, 東京, 1974.

• 2) Welin S:Uber moderne rontgenologische Dickdarmdiagnostik unter besonderer Berucksichtigung der Doppelkontrastmethode. Mun med Wschr, 100:1421, 1958.

• 3) Lockhart-Mummery HE, Morson BC:Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut, 1:87, 1960.
  pubmed

• 4) Janowitz HD, Lindner AE, Marshak RH:Granulomatous colitis. JAMA 191:825, 1965.
  pubmed

• 5) Lennard-Jones JE, Lockhar-Mummery HE, Morson BC:Clinical and pathological differentiation of Crohn's disease and proctocolitis. Gastroenterology, 54:1162, 1968.

• 6) Wolf BS, Marshak PH:Granulomatous colitis (Crohn's disease of the colon). Am J Roentgenol, 88:662, 1962.

• 7) Lockhart-Mummery HE, Morson BC:Crohn's disease of the large intestine. Gut, 5:493, 1964.
  pubmed

• 8) Farmer RG, Hawk WA, Turnbull RB:Clinical patterns in Crohn's disease:A statistical study of 615 cases. Gastroenterology, 68:627, 1975.
  pubmed

• 9) Bockus HL:Gastroenterology. Ed. 3 Vol. 2, Chap. 74. WB Saunders Company, Philadelphia, 1976.

• 10) Marshak RH, Lindner AE:Radiology of the small intestine. Philadelphia, WB Saunders Company, 1976.

• 11) 中島哲二, 煎本正博, 池永達雄:大腸クローン病の1例とX線診断. 胃と腸, 13:473, 1978.

• 12) 白壁彦夫:大腸疾患における診断とその限界, 日消病誌, 73:568, 1976.

• 13) Simpkins KC:Aphthoid ulcers in Crohn's colitis. Clin Radiol, 28:601, 1977.
  pubmed

• 14) Welin S, Welin G:Apathognomonic rcentgenologic sign of regional ileitis (Crohn's disease). Dis Colon Rectum, 16:473, 1973.

• 15) Kelvin FM et al:Double contrast barium enema in Crohn's disease and ulcerative colitis. Am J Roentgenol, 131:207, 1978.

• 16) 白壁彦夫ほか:大腸結核のX線診断. 胃と腸, 12:1597, 1977.

• 17) 丸山雅一ほか:回盲部結核症の診断-手術例12例についての考察. 胃と腸, 9:865, 1974.

• 18) Crohn BB, Ginzburg L, Oppenheimer GD:Regional ileitis. JAMA, 99:1323, 1932.

• 19) Brooke BN:Granulomatous disease of the intestine. Lancet, 2:745, 1959.
  pubmed

• 20) Morson BC, Lockhart-Mummery HE:Crohn's disease of the colon. Gastroenterologia 92:168, 1959.

• 21) 岡部治弥ほか:神奈川県下クローン病実態調査. クローン病調査研究班昭和51年度業績集:56, 1977.

• 22) 政信太郎, 西俣嘉人, 徳留一博:クローン病のX線診断, 文光堂, 東京, 1979.

• 23) Reuter SR, Redman HC:Gastrointestinal angiography. WB Saunders company, Philadelphia, 1977.

P.81 掲載の参考文献

• 1) Niwa, H., Utsumi, Y., Nakamura, T., Yoshitoshi, Y.:Endoscopy of the colon. Proc. lst Congr. Internat. Soc. Endoscopy p. 425, 1966.

• 2) 三枝純郎 (訳):下部結腸疾患の臨床 (Jackman, R. J. 著) 医学書院, 東京, 1967.

• 3) 丹羽寛文, 金子栄蔵, 梅田典嗣:胃内視鏡診断学. 南江堂, 東京, P. 26, 1975.

• 4) Brown, G. R.:A new approah to colon preparatlon for barium enema:preliminary report. Univ. Michigan Med. Bull. 27:225, 1961.

• 5) 丹羽寛文:大腸ファイバースコープ検査の偶発症-アンケートによる全国 集計-Gastroent. Endoscopy, 21:178, 1979.

• 6) 丹羽寛文, 三木一正, 藤野雅之, 平山洋二, 池田昌弘, 織田敏次:検査中の着脱を可能とした大腸Sliding Tubeの検討, Gastroent. Endoscopy, 20: 438, 1978.

• 7) 平塚秀雄:腸紐誘導式結腸ファイバースコープの挿入法ととくに回盲部観察成績について. 日消誌, 67:686, 1970.

• 8) 水野幸一, 西沢譲, 小林茂雄, 間山素行, 篠塚忠, 荻原奉祐, 野本一夫, 狩谷淳, 小野正己, 林学, 丸山俊秀:色素撒布による大腸粘膜小区像の検討. Prog. Dig. Endoscopy, 3:145, 1973.

• 9) 多田正大, 加藤三郎, 竹田彬一, 小林顕彦, 郡大裕, 宮岡孝幸, 川井啓市: 大腸内視鏡検査における色素撒布法の応用.

• 10) 岡本英樹, 古城治彦, 田中弘道, 五明田学:大腸粘膜の肉眼的微細模様と内視鏡診断への応用. Gastroent. Endoscopy, 16:598, 1974.

3. 潰瘍性大腸炎

P.96 掲載の参考文献

• 1) 稲田龍吉:重症大腸炎に就て, 日消誌, 27:625〜638, 1928.

• 2) 松永藤雄:第55同日本内科学会宿題報告, 潰瘍性大腸炎. 日本内科学会雑誌, 47:295-322, 1958.

• 3) 横田 曄, 宇都宮利善, 他:1)潰瘍性大腸炎の疫学, 厚生省特定疾患, 特発性腸管障害調査研究班. 昭和51年度業績集:123〜157, 1977.

• 4) 横田 曄, 宇都宮利善, 他:潰瘍性大腸炎<idiopathic procto-colitis>の疫学的研究 (第3報) 厚生省特定疾患, 特発性腸管障害調査研究班. 昭和52年度業績集:147-185, 1978.

• 5) 横田 曄, 宇都宮利善, 他:潰瘍性大腸炎<idiopathic procto-colitis>の疫学的研究 (第4報) 厚生省特定疾患, 特発性腸管障害調査研究班. 昭和53年度業績集:239-258, 1979.

• 6) 宇都宮利善, 横田 曄, 他:潰瘍性大腸炎<idiopathic procto-colitis>の疫学的研究報告 (第5報) 厚生省特定疾患, 炎症性腸管障害調査研究班. 昭和54年度業績集:140〜161, 1980.

• 7) Goligher J. C.. de Dombal F. T. et al:4. Epidemiology. Ulcerative Colitis:47-61. Bailliere Tindall and Cassell. 1968. London.

• 8) Bonnevie, O., Riis, P., and Anthouisen, P.:An Epidemiological Study of Ulcerative Colitis in Copenhagen County. Scand. J. Gastroent. 3:432-438, 1968.

• 9) Monk, M. Mendeloff, A. I., et al:An Epidemiological Study of Ulcerative Colitis and Regional Enteritis among Adults in Baltimore. I. Hospital Incidence and Prevalence, 1960 to 1963. Gastroenterology. 53:198-210, 1967.

• 10) Wigley, R, D., MacLaurin, B. P.:A study of Ulcerative Colitis in New Zealand, showing low incidence in Maoris. Brit. med. J., 2:228, 1962.
  pubmed

• 11) Evans, J. G. and Acheson, E. D.:An epidemiological study of ulcerative Colitis and regional enteritis in the Oxford area. Gut, 6:311-324, 1965.
  pubmed

• 12) Birnbaum, D., Groen, J. J., &Kallner, G.:Ulcerative colitis among the ethnic groups in Israel. Arch. intern. Med., 105:843, 1960.
  pubmed

• 13) 渡辺 晃, 樋渡信夫, 清治邦夫, 他:日本における難病研究の現況 (2) 潰瘍性大腸炎. 内科, 39:806-814, 1977.

• 14) Mendeloff, A. L.:The Epidemiology of Idiopathic Inflammatory Bowel Disease. Inflammatory Bowel Disease:3-19, Lea &Febiger 1975, Philadelphia.

• 15) Burch, P. R. J. et al:Aetiology of ulcerative colitis. II A new hypothesis. GUT 10:277-284, 1969.

• 16) Monk, M., Mendeloff, A. I. Siegel, C. I. &Lilienfeld, A.:An Epidemiological Study of Ulcerative Colitis and Regional Enteritis Among Adults in Baltimore, II Social and demographic factors. Gastroenterology 56:847-857, 1969.
  pubmed

• 17) 横田 曄, 宇都宮利善, 鈴木紘一:日本における潰瘍性大腸炎の統計. 胃と腸, 11:1023-1028, 1976.

• 18) Singer H.C., Anderson, J. G. D., Frischer, H.:Familial aspects of Inflammatory Bowel Disease. Gastroenterology, 61:423-430, 1971.

• 19) 土屋雅春, 他:潰瘍性大腸炎-成因をめぐって-最新医学, 31:1961-1967, 1976.
  Medical*Online

• 20) 横田 曄, 宇都宮利善:潰瘍性大腸炎の疫学. 内科Mook. 14:99-114, 1980.

P.108 掲載の参考文献

• 1) Burnham, W. R. et al.:Mycobacteria as a possible cause of inflammatory bowel disease. Lancet, II, 693, 1978.

• 2) Farmer, G. W. et al.:Viral investigation in ulcerative colitis and regional enteritis. Gastroenterology, 65:8, 1973.
  pubmed

• 3) Strickland, R. G. et al.:Lymphocytotoxic antibodies in patients with inflammatory bowel disease and their spouses-evidence for a transmissible agent. Clin. exp. Immunol, 30:188, 1977.
  pubmed

• 4) Gitnik, G. L. et al.:Evidence for the isolation of a new virus from ulcerative colitis patients. Dig. Dis. Sci., 24:609, 1979.

• 5) Andresen, A. F. R. et al.:Ulcerative colitis. an allergic phenomenon. Amer. J. Dig Dls., 9:91, 1942.

• 6) Falchuk, K. R. et al.:Circulating antibodies to bovine albumin in ulcerative colitis and Crohn's disease. Gastroenterology, 70:5, 1976.
  pubmed

• 7) Zeitlin, I. J. et al.:Mobilization of tissue kallikrein in inflammatory disease of the colon, Gut, 14:133, 1973.
  pubmed

• 8) Gould, S. R. et al.:Prostaglandins, ulcerative colitis and sulphasalazine. Lancet,II, 988, 1975.

• 9) Sharon, P. et al.:Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology, 75:638, 1978.
  pubmed

• 10) Broberger, O. et al.:Autoantibodies in human ulcerative colitis. J. Exp. Med., 110:657, 1959.
  pubmed

• 11) Strickland, R. G. et al.:Peripheral blood T and B cells in chronic inflammatory bowel disease. Gastroenterology, 67:569, 1974.

• 12) Brandtzaeg, P. et al.:Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis. Gastroenterology, 66:1123, 1974.
  pubmed

• 13) Lyanga, J. J. et al.:In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease:prevalence and relationship to disease activity immunoresponsiveness in IBD. Clin. exp. Immunol., 37:120, 1979.
  pubmed

• 14) Thayer, W. R. et al.:Escherichia coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease. Gastroenterology, 57:311, 1969.
  pubmed

• 15) Bull, D. M. et al.:Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease. Gastroenterology, 64:43, 1973.
  pubmed

• 16) Kovacs, A:Titre of anti E. coli antibodies in ulcerative colitis. Digestion, 10:205, 1974.

• 17) Lake, A. et al.:Complement alterations in infllammatory bowel disease. Gastroenterology, 76:1374, 1979.

• 18) Hodgson, H. J. F. et al:Immune complexes in ulcerative colitis and Crohn's disease. Clin. exp. Immunol., 29:187, 1977.

• 19) Soltis, R. D. et al.:Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease. Gastroenterology, 76:1380, 1979.
  pubmed

• 20) Potter, B. J. et al.:C1q metabolism in ulcerative colitis and Crohn's disease. Gut, 20:1012, 1979.

• 21) Das, K. M. et al.:Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. Proc. Natl. Acad. Sci. USA, 75:4528, 1978.
  pubmed

• 22) Bendixen, G.:Specific inhibition of the in vitro migration of leucocytes in ulcerative colitis and Crohn's disease. Scand. J. Gastrocnt., 2:214, 1967.
  pubmed

• 23) Perlmann, P. et al.:In vitro studies of ulcerative colitis. II. cytotoxic action of white blood cells from patients on human fetal colon cells. J. Exp. Med., 117:717, 1963.

• 24) Shorter, R. G. et al.:Inhibition of in vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and granulomatous colitis for allogenic colonic epithelial cells, using horse anti-human thymus serum. Gastroenterology, 54:227, 1968.
  pubmed

• 25) Shorter, R. G. et al.:Further studies of in vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogenic colonic epithelial cells, inducing the effects of colectomy. Gastroenterology, 56:304, 1969.

• 26) Shorter, R. G. et al.:Further studies of in vitro cytotoxicity of lymphocytes for colonic epithelial cells. Gastroenterology, 57:30, 1969.
  pubmed

• 27) Shorter, R. G. et al.:Modification of in vitro cytotoxicity of lymphocyets from patients with chronic ulcerative colitis or granulomatous colitisfor allogenic colonic epithelial cells. Gastroenterology, 58:692, 1970.
  pubmed

• 28) Shorter, R. G. et al:Effects of preliminary incubation of lymphocytes with serum on their cytotoxicity for colonic epithelial cells. Gastroenterology, 58:843, 1970.
  pubmed

• 29) Shorter, R. G. et al.:Inflammatory bowel disease. cytophilic antibodyand cytotoxicity of lymphocytes for colonic cells in vitro. Amer, J. Dig. Dis., 16:673, 1971.

• 30) Shorter, R. G. et al:Inflammatory bowel disease. The role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cells. Amer. J. Dig. Dis., 17:689, 1972.
  pubmed

• 31) Stobo, J. D. et al.:In vitro studies of inflammatory bowel disease. Gastroenterology, 70:171, 1976.
  pubmed

• 32) Kemler, B. J. et al.:Inflammatory bowel disease:study of cell mediated cytotoxicity for isolated human colonic epithelial cells. Gut, 21:353, 1980.

• 33) Meuwissen, S. G. M. et al.:Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocytes subpopulations. Gut, 17:770, 1976.

• 34) Bartnick, W. et al.:Isolation and characterizations of colonic intraepithelial and lamina proprial lymphocytes. Gastroenterology, 78:976, 1980.

• 35) Clancy, R. et al:Abscence of K cells in human gut mucosa. Gut, 19:273, 1978.

• 36) Bookmann, M. A. et al.:Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease. Gastroenterology, 77:503, 1979.

• 37) Chiba, M. et al:K-cell activity in lamina proprial lymphocytes from human colon. Dig. Dis. Sci., 24:817, 1979.

• 38) Jayson, M. I. V. et al.:Inflammatory bowel disease in ankylosing spondylitis. Gut, 11:506, 1970.

• 39) Mallas, E. et al.:Histocompatibility antigens in inflammatory bowel disease. Gut, 17:906, 1976.
  pubmed

• 40) Asquith, P. et al:Histocompatibility antigens in patients with inflammatory bowel disease. Lancet, 1. 113, 1974.
  pubmed

• 41) Tsuchiya, M, et al.:HLA antigens and ulcerative colitis in Japan. Digestion, 15:286, 1977.
  pubmed

• 42) Delpre, G. et al.:HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology, 78:1452, 1980.
  pubmed

• 43) Zweibaum, A. et al.:Realisation d'une colite ulcerohemorragique experimentale par immunization bacterienne. Path. et Biol., 16:813, 1963.

• 44) 小林絢三ら:大腸ならびに大腸菌抗原による実験的大腸炎. 消化器と免疫, No. 5, p. 85, 医歯薬出版, 東京, 1980.

P.127 掲載の参考文献

• 1) Bockus H. L.:Gastroenterology Vol 2. 3rd Ed p. 645. W. B. Saunders Co. Philadelphia London Toronto 1976.

• 2) Spiro H. M.:Clinical Gastroenterology p. 575. Mac Millan London, 1970.

• 3) Bercovitz Z. T., Kirsner T. B., Lindner A. E., Marshak, R. H., Menguy R. B. &Sommers S. C.:Ulcerative and granulomatous colitis Charles C. Thomas. Springfield Illinois 1973.

• 4) 松永藤雄:大腸疾患-その診かたと対策. 南江堂, 1977.

• 5) Truelove S. C. &Reynell P. C.:Diseases of the Digestive System. p. 428. Blackwell Scietific Publications Oxford London. Edinburgh 1972.

• 6) Bargen J. A.:Chronic Ulcerative Colitis. p. 21. Charles C. Thomas, Springfield Illinois 1969.

• 7) 厚生省特定疾患潰瘍性大腸炎調査研究班, 昭和49年度業績集.

• 8) 厚生省特定疾患潰瘍性大腸炎クローン病調査研究班, 昭和50年度業績集.

• 9) 丹羽寛文:腸疾患のX線診断. 中外医学社, 1973.

• 10) Welin S. &Brahme F.:The double contrast method in ulcerative colitis Acta Radiologica 55:257, 1961.
  pubmed

• 11) Schinz H. R. Baensch W. E. Frommhold W. Glauner R.:Uehlinger E &Wellauer J:Roentgen Diagnosis Vol. V Abdomen 2nd Amer. Ed. Grune &Stratton New York&London, 1967.

• 12) 狩谷 淳, 西沢 譲, 野本一夫, 伊藤俊夫, 上野正己, 林 学, 小林茂雄, 吉川保雄, 白壁彦夫:大腸二重造影法の基本的X線像について. 臨牀放射線, 16:885, 1971.

• 13) 内海胖, 丹羽寛文:消化管内視鏡診断学大系, 第10巻 大腸, p. 149, 医学 書店, 1974.

• 14) 三木一正, 鈴木 宏, 飯野四郎, 丹羽寛文, 織田敏次, 杉浦衛, 平野知行:潰瘍性大腸炎患者血清にみられる特異なアルカリフォスファターゼ. 日消病誌, 73:162, 1976.

• 15) Brahme, F.,:Granulomatons colitis, Roentgenologic appearance and course of the lesions. Amer. J. Roentogenol. 99:35, 1967.

• 16) Falchuck K. R., Perrotto J. L. &Isselbacher K. J.:Serum lysozyme in Crohn's disease and ulcerative colitis, N. Eng. J. Med. 292:395, 1975.

• 17) Peeters T. L, Vantrappen G. &Gebos K.:Serum lysozyme levels in Crohn's disease and ulcerative colitis, Gut 17:300, 1976.

• 18) Shanks, S. C. &Kreley P.:A Textbook of X-ray Diagnosis Vol 4, 4th ed., Lewis, London 1969.

P.147 掲載の参考文献

• 1) Truelove, S. C.:The management of ulcerative colitis. Brit. J. Clin. Practice, 28:5, 1974.

• 2) Truelove, S. C. & Witts, L. J.:Cortisone in ulcerative colitis. Final report on a therapeutic trial. Brit. Med. J., 2:4947, 1955.
  pubmed

• 3) Baron, J. H., Connell, A. M., Lennard-Jones, J. E. et al:Sulphasalazine and salicylazos ulphadimidine in ulcerative colitis. Lancet, 1:1094, 1962.

• 4) Truelove, S. C. &Watkinson. G.:Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. Brit. Med. J., 2:1708, 1962.
  pubmed

• 5) Misiewicz, J. J., Lennard-Jones, J. E. et al.:Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet, 1:185, 1965.

• 6) Lennard-Jones, J. E., Misiewicz, J. J. et al:Prednisolne as maintenance treatment for ulcerative colitis in remission. Lancet, 1:188, 1965.

• 7) Dissanayake, A. S. &Truelove. S. C.:A controlled therapeutic trial of longterm maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut, 14:923, 1973.
  pubmed

• 8) Riis, P., Anthonisen, P. et al:The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A doubleblind trial on patients asymptomatic for one year. Scand. J. Gastoent., 8:71, 1973.
  pubmed

• 9) Schreder, H. &Campbell, E. S.:Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin. Pharmacol. Ther., 13:539, 1972.

• 10) Azad Khan, A. K., Piris, J. &Truelove, S. C.:Experiment to determine the active therapeutic moiety of sulphasalazine. Gut, 18:A971, 1977.

• 11) Smith, P. R., Dawson, D. J. &Swan, C. H. J.:Prostaglandin synthetase activity in acute ulcerative colitis.:Effect of treatment with sulphasalazine, codein phosphate and prednisolone. Gut, 20:802, 1978.

• 12) Sharon, P., Ligumsky, M., et al.:Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroent, 75:1051, 1978.

• 13) 井上幹夫, 今井義治ほか:潰瘍性大腸炎および下剤による副作用. 臨床と研究, 53:115, 1976.

• 14) 松永藤雄ほか:潰瘍性大腸炎に対するリンデロン坐薬, サラゾピリン坐薬, およびサラゾピリン錠剤の有用性の検討. 基礎と臨床, 14:2486, 1980.

• 15) Roth, J. L. A.:Ulcerative colitis. in Gastroenterology ed. Bokus. H. L. Vol 2, p. 645, Saunders, Philadelphia, 1976.

• 16) Kirsner, J. B. &Goodman, M.:The medical treatment of inflammatory bowel disease. in Inflammatory Bowel Disease. ed. Kirsner, J. B. & Shorter. R. G. Lie & Febiger, Philadelphia, 1980.

• 17) Baron, J. H., Connell, A. M. et al.:Out patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone. Brit. Med. J., 2:441, 1962.
  pubmed

• 18) Jetzel. L:Treatment of ulcerative colitis. New Eng. J. Med., 271:891, 1964.

• 19) 馬場正三ほか:潰瘍性大腸炎に対する選択的プレドニン動注療法. 脈管学, 14:225, 1974.

• 20) Powell-Truck, J. et al. Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Brit. Med. J., 1:193, 1976.

• 21) Lee, D. A. H., Taylor, G. M. et al.:Plasma prednisolone levels andadrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut, 20:394, 1979.

• 22) Caprilli, R. et al:A doubleblind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis. Amer. J. Dig. Dis., 20:115, 1975.
  pubmed

• 23) Jewell, D. P. &Truelove, S. C.:Azathioprine in ulcerative colitis.:Final report on controlled therapeutic trial. Brit. Med. J., 4:627, 1974.
  pubmed

• 24) Rosenberg. J. L, Wall, A. J. et al.:A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroent., 69:96, 1975.

• 25) Korelitz, B. 1., Glass, J. L. &Wisch, N.:Long-term immunosuppressive therapy of ulcerative colitis.:Continuation of a personal series. Amer. J. Dig. Dis., 18:317, 1973.

• 26) Mani, V., Lloyd, G. et al.:Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled study. Lancet, 1:439, 1976.
  pubmed

• 27) Dronfield, M. W. &Longman, M. J. S.:Controlled comparison of sodium cromoglycate and sulphasalazine in the maintenance of remission in ulcerative colitis. Gut, 18:A973, 1977.

• 28) Heatley, R. V., Calcraft, B. J. et al:Disodium cromoglycate in the treatment of chronic proctitis. Gut, 16:559, 1975.
  pubmed

• 29) Riis, P.:A critical survey of controlled studies in the treatment of ulcerative colitis and Crohn's disease. Clinics in Gastroenteroenterology, 9:351, 1980.

• 30) Machella, T. E.:Chronic (non-specific) ulcerative colitis.:A reviews of medical therapy. Amer. J. Med. Sci., 222:579, 1951.

• 31) Lennard-Jones, J. E.:Observations on the treatment of colitis. Shweiz. Med. Wschr., 101:701, 1971.

• 32) Truelove, S. C. &Jewell, D. P.:Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet, 1:1067, 1974.
  pubmed

• 33) 井上幹夫, 今井義治ほか:潰瘍性大腸炎の内科的療法. 臨床と研究, 52: 2227, 1975.
  Medical*Online

• 34) 井上幹夫ほか:内科的治療分科会報告 厚生省特定疾患. 潰瘍性大腸炎クローン病調査研究班, 昭和50年度業績集, p. 5, 1976.

• 35) Huizenga, K. A.:Medical treatment and prognosis of some local complications of chronic ulcerative colitis and Crohn's disease. in Inflammatory Bowel Disease, ed. Kirsner&Shorter, R. G., Lea &Febiger, Fhiladelphia, 1980.

• 36) Cello, J. P. &Meyer, J. H.:Ulcerative colitis. in Gastrointestinal Disease. ed. Sleisenger, M. H. &Fordtran, J. S., Vol 2. Saunders, Philadelphia, 1978.

• 37) Korelitz, B. I.:Prognosis in inflammatory bowel Disease. -A north American view. in Inflammatory Bowel Disease. ed. Kirsner, J. B. &Shorter, R. G., Lie & Febiger. Philadelphia, 1980.

• 38) Truelove, S. C. &Willoughby, C. P.:Course and prognesis of ulcerative colitis and Crohn's disease. A european view. in Inflammatory Bowel Disease(同上)

• 39) Bockus. H. L., Roth, J. L. A., et al.:ulcerative colitis. a) Natural history. Gastroenterologia, 86:549, 1956.

• 40) Edwrd, F. C. &Truelove, S. C.:The prognosis of ulcerative colitis. Part I Short-term prognosis. Part II long-term prognosis. Gut, 4:299, 1963.

• 41) Watts, J. Mck., de Dombal, F. T. et al. Early course of ulcerative colitis. Gut, 7:16, 1966.

• 42) Watts, J. Mck., de Dombal, E T. et al:Long-term prognosis of ulcerative coliitis. Brit. med. J., 1:1447, 1966.

• 43) Jalan, K. N., Prescott, K. J. et al:An experience of ulcerative colitis. II Short term outcome. Gastroent., 59:589, 1970.

• 44) Jalan. K. N., Prescott, K. J. et al:An experience of ulcerative colitis. III Long term outcome. Gastroent., 59:598, 1970.

• 45) Bonnevie, O., Binder, V. & Riis, P. A.:the prognosis of ulcerative coltis. Scand. J. gastroent., 9:81, 1974.

• 46) 宇都宮利善,:横田曄ほか:潰瘍性大腸炎の疫学的研究報告 (第5報) . 厚生省特定疾患・炎症性腸管障害研究班, 昭和54年度業績集, p. 140, 1980.

• 47) 渡辺 晃, 樋渡信夫ほか:潰瘍性大腸炎の臨床的研究. 日消会誌, 74:765, 1977.

• 48) Morowitz, D. A. &Kirsner, J. B.:Mortality in ulcerative colitis:1930 to 1966. Gastroent., 57:481, 1969.

• 49) Gilat, T., Lilos, P. et al.:Risk factor in ulcerative colitis. Digestion, 14:408, 1976.

• 50) 井上幹夫, 吉田一郎ほか:潰瘍性大腸炎の診断と治療. 臨床と研究, 57: 2123, 1980.
  Medical*Online

• 51) Ritchie, J. T., Powell, J. &Lennard-Jones, J. E.:Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet, 1:1140, 1978.

• 52) 井上幹夫, 吉田一郎:潰瘍性大腸炎の経過および予後. 厚生省特定疾患・炎症性腸管障害, 昭和55年度業績集, 1981.

• 53) Newell, A. C. &Jones, F. A.:Observation on the management of idiopathic proctitis. Proc. Royal Soc. med., 51:431, 1958.

• 54) Sparberg, M., Fennessy, J. &Kirsner, J. B.:ulcerativ proctitis and mild ulcerative colitis. A study of 220 patients. medicine. 45:391, 1966.

• 55) 武藤徹一郎, 神谷直治ほか:治療, 58:1175, 1976.

• 56) morson, B. C. &Pang, L. S. C.:Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut, 8:423, 1967.

• 57) Myrvold, H. E., Kock, N. G. &Ahren, C.:Rectal biopsy and precancer in ulcerative colitis. Gut, 15:301, 1974.
  pubmed

• 58) Cock, M. G., Path, M. R. C. &Goligher, J. C.:Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroent., 68:1127, 1975.

• 59) Toovey, S., Hudson, E. et al.:Sulphasalalzine and male infertility:reversibility and possible mechanism. Gut, 22:445, 1981.
  pubmed

• 60) Birnie, G. G., McLeod, T. I. F. &Watkinson, G.:Incidence of sulpha. salazine-induced infertility. Gut, 22:452, 1981.

4. クローン病

P.166 掲載の参考文献

• 1) Lockhart-Mummery H. E., Morson B. C.:Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis, Gut, 1:87, 1960.
  pubmed

• 2) Crohn B. B., Ginzburg L, Oppenbeimer G. D.:Regional ileitis, JAMA, 99:1323, 1932.

• 3) Crohn B. B.:Granulomatous disease of the small intestine and large bowel, Gastroenterology, 52:767, 1967.

• 4) Kyle J.:Crohn's disease. William Heineman Medical Books limited, London. 1972.

• 5) Dalziel T. K.:Chronic interstitial enteritis, Brit Med J, 2:1068, 1913.

• 6) 土屋周二 (編):厚生省特定疾患クローン病調査研究班, 昭和51年度業績集.

• 7) 石川誠, 吉田豊:シンポジウム:腸の非特異性潰瘍. 日消会誌, 69:909, 1972.

• 8) Kyle J., Stark G.:Fall in the incidence of Crohn's disease, Gut, 21:340, 1980.
  pubmed

• 9) Mendeloff A. I. et al:Some epidemiological features of ulcerative colitis and regional enteritis. Gastroenterology. 51:748, 1966.
  pubmed

• 10) Evans J. G., Acheson E. D.:An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area, Gut, 6:311, 1965.
  pubmed

• 11) Kirsner J. B., Spencer J. A.:Family occurrences of ulcerative colitis, regional enteritis and ileocolitis, Ann Int Med, 59:133, 1963.
  pubmed

• 12) Lennard-Jones J. E.:Medical aspects of Crohn's disease, Proc, Roy, Soc, Med, 61:81, 1968.
  pubmed

• 13) Gjone E:私信文献(4).

• 14) Norlen B. J., Krause U., Bergman L.:An epidemiological study of Crohn's disease, Scand J. Gastroent, 5:385, 1970.
  pubmed

P.172 掲載の参考文献

• 1) Dalziel, T. K.:Chronic interstitial enteritis. Brit med. J., 2:1068, 1913.

• 2) Golde, D. W.:Aetiology of regional enteritis. Lancet, I, 1144, 1968.
  pubmed

• 3) Burmham, W. R. et al.:Mycobacteria as a possible cause of inflammatory bowel disease. Lancet, II, 693, 1978.

• 4) Aluwihare, A. P. R.:Electron microscopy in Crohn's disease. Gut, 12:509, 1971.

• 5) Mitchell, D. M. and Rees, R. J. W.:Agent transmissble from Crohn's disease tissue. Lancet, II, 168, 1970.

• 6) Cave, D. R. et al.:Further animal evidence of a transmissible agent in Crohn's disease. Lancet, II, 1120, 1973.

• 7) Cave, D. R. et al.:Experimental animal studies of the etiology and pathogenesis of Crohn's disease. Gastroenterology, 69:618, 1975.
  pubmed

• 8) Bolton, P. M. et al.:Negative finding in laboratory animals for a transmissible agent in Crohn's disease. Lancet, II, 1122, 1973.

• 9) Heatley, R. V. et al.:A search for a transmissible agent in Crohn's disease. Gut, 16:528, 1975.
  pubmed

• 10) Strickland, R. G. et al:Lymphocytotoxic antibodies in patients with inflammatory bowel disease and their spouses.-evidence for a transmissible agent. Clin. exp. Immunol., 30:188, 1977.
  pubmed

• 11) Farmer, G. W. et al.:Viral investigation in ulcerative colitis and regional enteritis. Gastroenterology, 65:8, 1973.
  pubmed

• 12) Roche, J. K. et al.:Viral DNA in inflammatory bowel disease. CMV bearing cells as a target for immune-mediated eterocytolysis. Gastroenterology, 72:228, 1977.
  pubmed

• 13) Aronson, M. D. et al:Isolation of a viral agent from intestinal tissue of patients with Crohn's disease and other intestinal disorders. Gastroenterology, 66:661, 1974.

• 14) Whorwell, P. J. et al.:Isolation of reovirus-like agents from patients with Crohn's disease. Lancet I, 1169, 1977.
  pubmed

• 15) Gitnick, G. L et al.:Cultivation of viral agents from Crohn's disease. A new sensitive system. Lancet, I, 215, 1976
  pubmed

• 16) Gitnick, G. L et al.:Electron microscopic studies of viral agents in Crohn's diseasse. Lancet, I, 217, 1976.

• 17) Phillpotte, R. J. et al.:Virus isolation studies in Crohn's disease:a negative report. Gut, 20:1057, 1979.

• 18) Thayer, W. R. et al.:Escherichia coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease. Gastroenterology, 57:311, 1969.
  pubmed

• 19) Bull, D. M. et al.:Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease. Gastroenterology, 64:43, 1973.
  pubmed

• 20) Hodgson, H. J. F. et al.:Immune complexes in ulcerative colitis and Crohn's disease. Clin. exp. Immunol., 29:187, 1977.

• 21) Soltis, R. D. et al.:Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease. Gastroenterology, 76:1380, 1979.
  pubmed

• 22) Lake, A. M. et al.:Complement alterations in inflammatory bowel disease. Gastroenterology. 76:1374, 1979.
  pubmed

• 23) Potter, B. J. et al:C1q metabolism in ulcerative colitis and Crohn's disease. Gut, 20:1012, 1979.

• 24) Guillou. P. J. et al.:Lymphocyte transformation in the mesenteric lymphonodes of patient with Crohn's disease. Gut, 14:20, 1973.

• 25) Richens, E. R. et al.:Mixed-lymphocyte reaction as a measure of immunological component of lymphocytes patients with Crohn's disease. Gut, 15:24, 1974.

• 26) Shorter, R. G. et al.:Inflammatory bowel disease. the role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cell Amer. J. Dig. Dis. 17:689, 1972.
  pubmed

• 27) Stobo, J. D. et al.:In vitro studies of inflammatory bowel disease. Gastroenterology, 70:171, 1976.
  pubmed

• 28) Kemler, B. J. et al.:Inflammatory bowel disease;Study of cell mediated cytotoxicity for isolated human colonic epithelial cells. Gut, 21:353, 1980.
  pubmed

• 29) Lyanga, J. J. et al.:In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease;prevalence and relationship to disease activity immunoresponsiveness in IBD. Clin. exp. Immunol., 37:120, 1979.
  pubmed

• 30) Britton, S. et al:Appearance of Killer (k) cells in the mesenteric lymphnodes in Crohn's disease. Gastroenterology, 75:218, 1978.

• 31) Chiba, M. et al.:K-cell activity in lamina proprial lymphocytes from the human colon. Dig. Dis Sci, 24:817, 1979.

• 32) Eade, O. E. et al.:Lymphocyte subpopulation of intestinal mucosa in inflamatory bowel disease. Gut, 21:675, 1980.

• 33) Clancy, R. et al.:Absence of K cells in human gut mucosa Gut, 19:273, 1978.

• 34) Bookmann, M. A. et al.:Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease. Gastroenterology, 77:503, 1979.

• 35) Mayberry, J. F. et al.:Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Brit. Med. J., 280:84, 1980.
  pubmed

• 36) Asquith, P. et al.:Histocompatibility antigens in patients with inflammatory bowel disease. Lancet, I, 113, 1974.
  pubmed

• 37) Mallas, E. et al:Histocompatibility antigens in inflammatory bowel disease. Gut, 17:906, 1976.
  pubmed

• 38) Delpre, G. et al.:HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology, 78:1452, 1980.
  pubmed

P.196 掲載の参考文献

• 1) The Japanese Research Committee for Crohn's Disease:Crohn's disease in Japan. Gastroenterologia Japonica, 14:366, 1979;日本消化器病学会クローン病検討委員会:日本人のクローン病. 診断と治療, 67:2333, 1979.

• 2) 笹川 力, 木村明:疫学分科会報告-クローン病患者の精密調査成績. 厚生省特定疾患クローン病調査研究班昭和52年度業績集, p. 6, 1978.

• 3) Provisional International Nomenclature, Vol. III:Diseases of the Gastrointestinal Tract, edited by S. Btesh, p. 45;65, CIOMS, Geneva, 1973.

• 4) 日本消化器病学会クローン病検討委員会:クローン病診断基準 (案) . 日消誌, 73:1467, 1976;74:404, 1977.

• 5) 笹川 力, 木村 明:クローン病の疫学. 厚生省特定疾患炎症性腸管障害調査研究班昭和54年度業績集, p. 162, 1980.

• 6) Hofmann, A. F.:The syndrome of ileal disease and the broken enterohepatic cholerheic enteropathy. Gastroenterology, 52:752, 1967.
  pubmed

• 7) 渡辺 晃:診断基準分科会報告. 厚生省特定疾患クローン病調査研究班昭和51年度業績集, p.4, 1977.

• 8) Watanabe, H., Hiwatashi, N., Goto, Y.:Biopsy under direct vision for the diagnosis of Crohn's Disease. Tohoku J. exp. Med., 129:1, 1979.
  pubmed

P.207 掲載の参考文献

• 1) 日本消化器病学会クローン病検討委員会 (委員長 山形敞一):クローン病診断基隼 (案) . 日消誌, 73:1467, 1976.

• 2) 笹川 力他:疫学分科会報告-クローン病患者の精密調査成績. 厚生省特定疾患クローン病調査研究班昭和52年度業績集, p. 6, 1978.

• 3) Bockus H. L:Regional Enteritis (Crohn's Disease) Part II. Clinical Features. Gastroenterology (ed. by Bockus) Vol. II 3 rd ed. p. 561, Saunders, Philadelphia, 1976.

• 4) Truelove S. C. et al.:Course and prognosis of Crohn's disease. Gut 17:192, 1976.
  pubmed

• 5) De Dombal F. T. et al.:Short-term course and prognosis of Crohn's disease. Gut 15:435, 1974.
  pubmed

• 6) Stahlgren L. H. et al.:The result of surgical treatment of chronic regional enteritis. JAMA, 175:986, 1961.

• 7) Cooke W. T.:Survey of results of treatment of Crohn's disease. Clinics in gastroenterology 1 (2):521, W. B. Saunders, Philadelphia, 1972.

• 8) van Patter W. N. et al.:Regional enteritis. Gastroenterology, 26:347, 1954.
  pubmed

• 9) Colcock B. P. et al.:Surgical treatment of regional enteritis. New Engl. J. Med. 262:435, 1960.
  pubmed

• 10) Lennard-Jones J. E. et al.:Prognosis after resection of chronic regional ileitis. Gut, 8:332, 1967.
  pubmed

• 11) Brill C. B. et al:Regional enteritis and entero-colitis:a study of 74 patients over 15 years. Ann. Surg. 170:766, 1969.
  pubmed

• 12) De Dombal F. T. et al.:Recurrence of Crohn's disease after primary excisional surgery. Gut, 12:519, 1971.
  pubmed

• 13) Greenstein A. J. et al.:Reoperation and recurrence in Crohn's colitis and ileocolitis. New Engl. J. Med. 293:685, 1975.
  pubmed

• 14) Stone W. et al.:The dilemma of Crohn's disease:Long-term follow-up of Crohn's disease of the small intestine. Dis. Col. &Rect. 20:372, 1977.

• 15) Bargen J. A. et al.:Nonsurgical management of regional enteritis. JAMA, 165:2045, 1957.

• 16) Kyle J.:Surgery of regional enteritis. Aust. NZ J. Surg. 34:116, 1964.

• 17) Cornes J. S. et al.:Primary Crohn's disease of the colon and rectum. Gut, 2:189, 1961.
  pubmed

• 18) Jones J. H. et al.:Experience in the treatment of Crohn's disease of the large intestine. Gut, 71448, 1966.

• 19) Nugent F. W. et al.:Prognosis after colonic resection for Crohn's disease of the colon, Gastroenterology, 65:398, 1973.
  pubmed

• 20) Atwell J. D. et al.:The outcome of Crohn's disease. Brit. J. Surg. 52:966, 1965.
  pubmed

• 21) De Dombal F. T. et al.:The results of surgical treatment for Crohn's disease. Brit. J. Surg. 59:826, 1971.

• 22) Prior P. et al:Mortality in Crohn's disease. Lancet, 1:1135, 1970.
  pubmed

• 23) Valdes-Dapena A. et al:Adenocarcinoma of the small bowel in association with regional enteritis:Four new cases. Cancer, 37:2938, 1976.
  pubmed

• 24) Nesbit R. R. et al.:Carcinoma of the small bowel:a complication of regional enteritis. Cancer, 37:2948, 1976.
  pubmed

• 25) Weedon D. D. et al.:Crohn's disease and cancer. New Engl. J. Med. 289:1099, 1973.
  pubmed

• 26) Fielding J. F. et al.:Malignancy in Crohn's disease. Scand. J. Gastroenterol. 7:3, 1972.
  pubmed

• 27) Perrett A. D. et al.:Crohn's disease and carcinoma of colon. Brit. Med. J. 2:466, 1968.
  pubmed

• 28) Edwards F. C. et al.:The course and prognosis of ulcerative colitis:Part III complications. Gut, 5:1, 1964.

• 29) 平山洋二他:大腸クローン病の一例. Progress of Digestive Endoscopy, 4:158, 1974.

• 30) 丹羽寛文他:大腸クローン病長期経過追求例のX線・内視鏡像の推移. 厚生省特定疾患クローン病調査研究班昭和52年度業績集, p.42, 1978.

P.220 掲載の参考文献

• 1) Best R. W., Becktel J. M., Singleton J. W. and Kern F.:Development of a Crohn's disease activity index-National Cooperative Crohn's disease study, Gastroenterology, 70 (3), 439-444, 1976.

• 2) Steiger E., Wilmore D. W.:Total intravenous nutrition in the management of in flammatory disease of the intestinal tract. Fed. Proc. 28:808, 1969.

• 3) Babb R. R.:The role of total Parenteral nutrition in the treatment of inflammatory bowel disease. American Journal of Gastroenterology, 70 (5):506-509, 1978.
  pubmed

• 4) Gudmand-Hoyer E. and Jornum S.:Incidence and clinical significance of lactose malabsorption in ulcerative colitis and Crohn's disease. Gut. 11:338-343, 1970.
  pubmed

• 5) Andersson H. and Jagenburg R.:Fat-reduced diet in the treatment of hyperoxaluria in patients with ileopathy. Gut 15:360-366, 1974.
  pubmed

• 6) Lennard J. E. and Powell-Tuck J.:Drug Treatment of Inflammatory Bowel Disease. Clinics in Gastroenterology. 8 (1):187-217, 1979.

• 7) Cline M. J. and Melmon K. L.:Plasma kinins and cortisol:A possible explanation of the anti-inflammatory action of cortisol, Science, 153:1135-1138, 1966.
  pubmed

• 8) Weissmann G.:The role of lysosomes in inflammation and disease. Ann Rev of Med, 18:97-112, 1967.

• 9) Lewis G. P. and Piper P. J.:Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature, 254:308-311, 1975.
  pubmed

• 10) Cooke W. T. and Fielding J. F,:Corticosteroid or Corticotrophin therapy in Crohn's disease (regional enteritis). Gut, 11:921-927, 1970.

• 11) Singleton J. W.:National Cooperative Crohn's Study (NCCDS):Preliminary results of part 1. A Comparative study. Gastroenterology, 70 (5):938, 1976.

• 12) Singleton J. W. National Cooperative Crohn's Disease Study (NCCDS):Results of drug treatment. Gastroenterology, 72:1133, 1977.

• 13) Smith R. C., Rhodes J., Heatley R. V., Hughes L. E., Crosby D. L., Rees B, I., Jones H., Evans K. T. and Lawrie B. W. Low-dose steroids and clinical relapse in Crohn's disease:a controlled trial. Gut, 19:606-610, 1978.

• 14) Bockus. H. L.:Gastroenterology. vol. II. 3rd Ed, W. B. Saunders Co., Philadelphia. London Toronto, 1976.

• 15) Weterman I. T., Perna A. S. and Booth C. C.:The management of Crohn's disease, Excepta Medica, Amsterdam-Oxford, 1976.

• 16) Lendrum R, Walker J. G., West B. and Hill M. J.:Effects of sulphasalazine (Salazopyrine) on faecal fiora in patients with inflammatory bowel disease. Gut, 15:344, 1974.

• 17) Gould S. R. and Lennard-Jonnes J. E.:Production of prostaglandins in ulcerative colitis and their inhibition by sulphasalazine. Gut. 17:828, 1976.

• 18) Harris J., Archampong E. O. and Clark C. G.:The effect of Salazopyrine on water and electrolyte transport in the human colon measured in vivo and in vitro. Gut, 13:855, 1972.

• 19) A multicentre trial,:sulphasalazine in asymptomatic Crohn's disease. Gut. 18:69-72, 1977.
  pubmed

• 20) Van Hees P. A., Van Elferen L. W. and Van Rossum J. M.:Hemolysis during salicylazosulphapyridine therapy. Am. J. Gastroenterology, 70:501-505, 1979.

• 21) Eckhardt R., Kloos P., Dierich M. P. and Meyer zum BUshenfela:e K. H.:K-lymphocytes (Killer-cells) in Crohn's disease and acute virus B-hepatitis. Gut. 18:1010-1016, 1977.

• 22) Campbell A. C., Skinner J. M., Hersey P., Mac-Lennan I. C. M. and Truelove S. C.:Immunosuppression in the treatment of inflammatory bowel disease. I. changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clinical and experimental Immunology. 16:521-533, 1974.

• 23) O'Donoghue D. P., Dawson A. M., Powell-Tuck J, Bown R. L and Lennard-Jones J. E.:Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease, The Lancet, 955-957, 1978.

• 24) Summers R. W. and Singleton J. W.:National Cooperative Crohn's disease Study (NCCDS):a controlled prospective trial of three drugs vs placebo. Gut, 18:A927, 1977.

• 25) Present, D. H., Wisch N., Glass J. L. and Korelitz B. I.:The efficacy of immunosuppressive therapy in Crohn's disease. A randomized long-term double blind study. Gastroenterology, 72:A911/114, 1977.

• 26) Moss A. A., Carbon J. V. and Kressel H. Y.:Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. Am. J. Roentgenol. 131:787-790, 1978.

• 27) Mainguet P. and Fiasse R.:Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection. Gut, 18:575-579, 1977.
  pubmed

• 28) Vicary F. R., Chambers J. D. and Dhillon P.:Double-blind trial of the use of transfer factor in the treatment of Crohn's disease. Gut, 20:408-413, 1979.
  pubmed

• 29) Rahban S., Sherman J. H., Opelz G., Conley D. R., Panish J. F., Marks J. W., Terasaki P. I. and Schoenfield L. J.:BCG Treatment of Crohn's disease Am. J. Gastroenterology, 71 (2):196-201, 1979.

• 30) Wesdorp E., Schellenken P. T. A., Weening R. S., Meuwissen S. G. M. and Tytgat G. N.:Levamisole in Crohn's disease a double blind controlled trial. Digestion, 18:186-191, 1978.